Bruker (BRKR) PT Lowered to $43 at Barclays
Barclays analyst Luke Sergott lowered the price target on Bruker (NASDAQ: BRKR) to $43.00 (from $46.00) while maintaining a Overweight ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
